[POISONING BY PSYCHOPHARMACOLOGICAL DRUGS IN AZERBAIJAN: THE RESULTS OF 8-YEAR PROSPECTIVE OBSERVATION].
Afandiyev I, Azizov V.
Georgian Med News. 2017 Nov;(272):138-144.
Carbamazepine-induced hyperglycemia: A rare case report.
Harika V, Parveen S, Venkatasubbaiah M, Varma KVS, Devasree S.
Indian J Pharmacol. 2019 Sep-Oct;51(5):352-353. doi: 10.4103/ijp.IJP_537_18. Epub 2019 Nov 26.
Tricyclic antidepressant toxicity.
Rose JB.
Clin Toxicol. 1977;11(4):391-402. doi: 10.3109/15563657708988202.
Dibenzazepine combats acute liver injury in rats via amendments of Notch signaling and activation of autophagy.
Ahmed LA, Abd El-Rhman RH, Gad AM, Hassaneen SK, El-Yamany MF.
Naunyn Schmiedebergs Arch Pharmacol. 2021 Feb;394(2):337-348. doi: 10.1007/s00210-020-01977-0. Epub 2020 Sep 28.
Postmortem toxicology of carbamazepine.
Klys M, Bystrowska B, Bujak-Gizycka B.
J Anal Toxicol. 2003 May-Jun;27(4):243-8. doi: 10.1093/jat/27.4.243.
Identification and determination of opipramol metabolites in plasma and urine.
Lappenberg-Pelzer M.
J Anal Toxicol. 1998 May-Jun;22(3):215-9. doi: 10.1093/jat/22.3.215.
Experimental and theoretical insight into carbamazepine degradation by chlorine-based advanced oxidation processes: Efficiency, energy consumption, mechanism and DBPs formation.
Liu C, How ZT, Ju Y, Feng L, Ren X, Gamal El-Din M.
J Environ Sci (China). 2024 May;139:72-83. doi: 10.1016/j.jes.2023.05.012. Epub 2023 May 22.
Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay.
Snyder RD, Arnone MR.
Mutat Res. 2002 Jun 19;503(1-2):21-35. doi: 10.1016/s0027-5107(02)00028-3.
Relationship of cardiovascular complications with level of consciousness in patients with acute carbamazepine intoxication.
Gheshlaghi F, Yaraghi A, Soh EH, Ghoreishi A.
Med Arh. 2012;66(1):9-11. doi: 10.5455/medarh.2012.66.9-11.
Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB, Janssen TJ, Hekster YA, Termond EF, van de Dries AC, Wijnands WJ.
Ther Drug Monit. 1986;8(3):297-304. doi: 10.1097/00007691-198609000-00011.
